Business context and reporting period
Markel Corporation (the filing registrant; identified in the request as Markel Group Inc.) filed this Form 10-K for the fiscal year ended December 31, 2021. Its three principal financial engines are specialty insurance and reinsurance, investments, and Markel Ventures, a portfolio of non-insurance businesses. Results are compared primarily with 2020.
Financial performance and position
| Metric | 2021 | 2020 |
|---|---|---|
| Total operating revenues | $12.85 billion | $9.74 billion |
| Operating income | $3.24 billion | $1.27 billion |
| Net income to common shareholders | $2.39 billion; diluted EPS $176.51 | $798 million; diluted EPS $55.63 |
| Comprehensive income to shareholders | $2.08 billion | $1.19 billion |
| Earned premiums | $6.50 billion | $5.61 billion |
| Underwriting profit | $628 million | $128 million |
| U.S. GAAP combined ratio | 90.3% | 97.7% |
| Net cash from operating activities | $2.27 billion | $1.74 billion |
| Invested assets | $28.29 billion | $24.93 billion |
| Total assets / shareholders’ equity | $48.45 billion / $14.70 billion | $41.71 billion / $12.80 billion |
Higher investment gains and stronger underwriting were the principal drivers of the earnings improvement. Net investment gains were $1.98 billion versus $618 million, largely reflecting increases in equity-security values. Net investment income was $375 million, broadly unchanged from $372 million; investment yield declined to 2.0% from 2.4%. Fixed-maturity securities’ unrealized gains fell by $450 million, compared with a $442 million increase in 2020, reflecting higher interest rates. The taxable-equivalent total investment return was 8.8%, versus 9.4%.
Insurance segment underwriting profit rose to $696 million from $169 million, with a combined ratio of 87.3% versus 96.4%. Reinsurance reported a $55 million underwriting loss, compared with a $34 million loss, and its combined ratio worsened to 105.3% from 103.7%. Markel Ventures revenue increased 30% to $3.64 billion; operating income was $273 million, up 7%, and EBITDA was $403 million, up 10% (EBITDA is non-GAAP).
Debt and liquidity: senior long-term and other debt was $4.36 billion, versus $3.48 billion, and consolidated debt-to-capital was 23%, versus 21%. The company issued $600 million of 3.45% senior notes due 2052 in May 2021. No borrowings were outstanding on its $300 million revolving credit facility, which expires in April 2024. Holding-company invested assets were $5.3 billion; insurance subsidiaries and Markel Bermuda could pay up to $1.3 billion in ordinary dividends over the following 12 months, subject to applicable limits. Management said liquidity was adequate for expected capital and operating needs. The filing does not provide a conventional current ratio or a companywide free-cash-flow measure.
Material changes versus 2020
- Gross premium volume in underwriting operations increased 19% to $8.48 billion; net written premiums rose 20% and earned premiums 16%. Favorable rates and new business, particularly in professional and general liability, supported growth.
- Underwriting results benefited from the absence of the prior year’s $358 million of COVID-19 losses. In 2021, catastrophe losses were $195 million and the company increased its COVID-19 loss estimate by $16 million. Favorable prior-year reserve development declined to $480 million from $606 million.
- Net income to common shareholders increased sharply, but the comparison also reflects 2020 market volatility and a 2020 tax benefit; the effective tax rate was 22% in 2021 versus 17% in 2020.
- Operating cash flow increased, while investing cash outflow rose to $2.94 billion, including $2.5 billion of net purchases of fixed maturities and cash used for acquisitions. Share repurchases totaled $207 million, compared with $27 million.
- Markel acquired Buckner HeavyLift Cranes and a controlling interest in Metromont in 2021. Metromont’s operating results were to be consolidated beginning in January 2022. It also acquired Lansing in 2020.
- Effective January 2021, Markel stopped bearing risk on new property reinsurance business in its Reinsurance division, shifting eligible business to third-party ILS capital. It discontinued property retrocessional reinsurance effective January 2022.
Outlook, risks, contingencies and unusual items
Management reported generally favorable insurance pricing trends, especially in professional and general liability, while workers’ compensation continued to see low-single-digit rate decreases. It cited economic and social inflation, litigation and claim-severity uncertainty as concerns for longer-tail lines. Management said it expected less underwriting volatility following changes to its reinsurance strategy, but provided no formal earnings or revenue guidance. It cautioned against relying unduly on favorable reserve trends; its reasonably likely 2022 range was favorable development of 2% to 7% of year-end 2021 net loss reserves, approximately $200 million to $750 million.
- Loss reserves are a significant estimation risk: unpaid losses and loss adjustment expenses were $18.18 billion, including $6.88 billion of reinsurance recoverables. IBNR represented 67% of reserves. The auditor identified reserve estimation as a critical audit matter; KPMG issued unqualified opinions on the financial statements and internal controls.
- Catastrophe and pandemic claims remain uncertain. COVID-19 loss estimates depend on policy coverage, litigation and reinsurance recoveries; management said future adjustments could be material. Exposure also includes weather-related catastrophe risk and potential climate-related effects.
- Reinsurance and fronting create counterparty exposure. Markel reported $7.3 billion of reinsurance recoverables and $3.7 billion of collateral overall. Recoverables are not risk-free, and the company remains liable to policyholders if reinsurers do not pay.
- Equity-price concentration is material: equity securities were 61% of shareholders’ equity, and the ten largest holdings were 43% of the equity portfolio. A hypothetical 35% equity-price decline would reduce shareholders’ equity by an estimated 17%, according to the filing’s sensitivity analysis.
- Markel Ventures faced higher material, labor and shipping costs and inflation; mitigation through pricing and sourcing actions may lag or prove insufficient. Other risks include competition, broker concentration, regulation, cyber incidents, acquisitions and access to third-party ILS capital.
- Nephila assets under management declined to $8.8 billion from $9.6 billion amid catastrophe losses and market volatility. The company reported no goodwill impairment, but Nephila’s valuation remains sensitive to assumptions about future cash flows and capital flows.
- Markel CATCo’s SEC and DOJ investigations concluded in September 2021 without enforcement action against MCIM; the filing said there were no pending BMA requests. Investor litigation remained a risk. A proposed transaction to accelerate return of capital was subject to investor and court approvals; estimated company cash funding was not expected to exceed $175 million, with $145 million of estimated tail-risk cover and $120 million of estimated payments to or for investors.
- In the Yeransian contingent-value-right dispute, independent experts determined a final $22.4 million valuation excluding interest; Markel made a $20.1 million payment in September 2021. The consolidated lawsuits remained pending, but the company considered them without merit and any material loss remote.
Important facts for investors to verify
- Whether favorable reserve development persists, and whether inflation, social inflation or new claim information leads to reserve strengthening.
- Actual ultimate costs of COVID-19 and 2021 catastrophe claims, and the collectability and timing of related reinsurance recoveries.
- Performance of the Reinsurance segment after the withdrawal from risk-bearing property reinsurance, including remaining legacy exposure and the effect of ceded arrangements.
- Equity portfolio concentration and sensitivity to market declines, alongside the impact of rising rates on fixed-maturity values and investment income.
- Markel CATCo transaction approvals, final costs and any further investor claims or regulatory developments.
- Integration and returns from acquisitions, Markel Ventures margin resilience amid cost inflation, and the evolution of Nephila assets under management and goodwill assumptions.
- Debt maturities, capital allocation and share repurchases; the filing disclosed a new $750 million repurchase authorization in February 2022 and no expected common-stock cash dividend under the company’s stated policy.